Professor, Fellowship Program Director
Pediatric Hematology Oncology Program
Area of interest
Blatt’s interests are in pediatric solid tumors, vascular anomalies, and drug repurposing as applied to both of those areas of interest.
Blatt’s clinical interests include late effects of chemotherapy, experimental therapeutics of solid tumors, and vascular anomalies.
Blatt’s research interests fall into several areas of clinical research. The first is in Late Effects of Childhood Cancer Therapy. Past studies have focused on gonadal function, cardiotoxicity and the development of second malignancies. She has been a consultant to the Childhood Cancer Survivor Study, a multicenter NIH-funded study which is examining late effects in more than 20,000 survivors of childhood cancer. She also is a past member of the Strategy Group of the Surveillance and End Results Committee of the Children’s Oncology Group, which generates late effects study components of therapeutic trials. Current research is focused on adolescent young adult survivorship issues.
A second interest is in experimental therapeutics of childhood cancer and related diseases. Current studies involve the effects of rapamycin on solid tumors, and on drug repurposing for pediatric hematology oncology.
A newer interest is in the treatment and biology of vascular lesions including hemangiomas and vascular malformations. Her division is part of a growing multidisciplinary “clinic without walls” effort to treat these patients.
Awards and Honors
Ad hoc member of EU grants on experimental therapeutics.